DEERFIELD, Ill., March 27, 2013 - Baxter International (NYSE:BAX), will host a quarterly conference call to discuss its first quarter 2013 financial results on Thursday, April 18, 2013, at 7:30 a.m. Central Time. To access the call, please dial 866-802-4322 (domestic) or 703-639-1319 (international). Please dial into the call at least ten minutes prior to the start of the call for the operator to connect you.
This call is being webcast by Thomson Reuters and can be accessed at Baxter's Web site at www.baxter.com. The conference call will be recorded by Baxter and is copyrighted material. It cannot be recorded or rebroadcast without Baxter's permission.
Baxter International, Inc. develops, manufactures and markets products that save and sustain the lives of people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma, and other chronic and acute medical conditions. As a global, diversified healthcare company, Baxter applies a unique combination of expertise in medical devices, pharmaceuticals and biotechnology to create products that advance patient care worldwide.